Test Price
2,800 AED✅ Home Collection Available
TNNT2 Gene Cardiomyopathy (Familial Hypertrophic Type 2) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing and bioinformatic validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed genetic counsellor for result interpretation and family risk assessment.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TNNT2 Genetic Test comprehensively analyzes the entire coding region of the TNNT2 gene to detect pathogenic variants causing familial hypertrophic cardiomyopathy type 2. This high-resolution test is essential for confirming a clinical diagnosis, guiding personalised treatment, and identifying at-risk family members before symptoms develop.
| Feature | Our TNNT2 NGS Test | Standard Single-Gene Sequencing |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with MLPA validation | Sanger sequencing (limited to known hotspots) |
| Diagnostic Sensitivity | 99.9% for all coding variants | ~85% for selected exons only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Clinical Report | DHA-compliant, includes variant classification (ACMG) and family risk | Basic mutation present/absent |
| Counselling Support | Pre- and post-test genetic counselling included | Often not provided |
Physician Insight & Safety Protocols
“A positive TNNT2 result must be interpreted within the full clinical context, including echocardiography, family history, and symptoms. Cascade screening of first-degree relatives is strongly recommended, and every result should be reviewed with a multidisciplinary team to guide personalised care. Pre- and post-test genetic counselling ensures informed decision-making and appropriate risk management.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue prescribed medication (e.g., beta-blockers, antiarrhythmics) without consulting your treating cardiologist. Abrupt cessation can trigger life-threatening arrhythmias.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria – Testing Not Recommended If:
- Minors (<18 years) without legal guardian consent (as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Individuals unable to provide informed consent for genetic testing.
- Active severe infection or acute cardiovascular event — postpone blood draw until stabilised.
- Patients with a known bleeding disorder must inform the phlebotomist; we can arrange an alternative dried blood spot collection.
Seek Immediate Medical Attention If You Experience:
- Sudden chest pain or pressure
- Unexplained fainting (syncope)
- Severe shortness of breath at rest
- Irregular, rapid heartbeats with dizziness
Patient FAQ & Clinical Guidance
1. Why do I need this TNNT2 genetic test if my echo already shows hypertrophic cardiomyopathy?
This NGS test identifies the exact TNNT2 variant, enabling definitive diagnosis, accurate family screening, and personalised clinical management beyond echocardiographic findings.
2. How long does the TNNT2 test result take and what does it include?
Results are delivered within 3–4 weeks and include a comprehensive report with variant classification (pathogenic, likely pathogenic) per ACMG guidelines, family screening recommendations, and complementary post-test genetic counselling.
3. Is home blood collection safe and accredited for genetic testing in the UAE?
Yes, our ISO 9001:2015 certified home phlebotomy team follows strict cold-chain protocols and DHA guidelines, ensuring sample integrity identical to hospital collection standards.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
This test adheres to the following UAE legal and regulatory standards:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – genomic data encrypted and stored on UAE-based servers.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – secure electronic health data handling.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – informed consent requirements for genetic testing.
- ISO 9001:2015 Certified Facility – Cert: INT/EGQ/2509DA/3139.
- DHA Facility License No. 1143
For compliance documentation or direct billing inquiries: WhatsApp +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | TNNT2 Gene Cardiomyopathy (Familial Hypertrophic Type 2) Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next-Generation Sequencing (NGS) with MLPA validation |
| ICD-10-CM Code | I42.1 |
| LOINC Code | 83290-0 |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians